Highline Wealth Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.75K | Sell |
20
-4
| -17% | -$349 | ﹤0.01% | 655 |
|
|
2025
Q1 | $1.64K | Buy |
24
+4
| +20% | +$273 | ﹤0.01% | 664 |
|
|
2024
Q4 | $1.56K | Buy |
20
+11
| +122% | +$855 | ﹤0.01% | 484 |
|
|
2024
Q3 | $603 | Sell |
9
-7
| -44% | -$469 | ﹤0.01% | 548 |
|
|
2024
Q2 | $1.81K | Buy |
16
+2
| +14% | +$227 | ﹤0.01% | 404 |
|
|
2024
Q1 | $1.94K | Hold |
14
| – | – | ﹤0.01% | 333 |
|
|
2023
Q4 | $1.74K | Hold |
14
| – | – | ﹤0.01% | 309 |
|
|
2023
Q3 | $1.31K | Hold |
14
| – | – | ﹤0.01% | 298 |
|
|
2023
Q2 | $1.8K | Hold |
14
| – | – | ﹤0.01% | 235 |
|
|
2023
Q1 | $1.63K | Hold |
14
| – | – | ﹤0.01% | 245 |
|
|
2022
Q4 | $1.59K | Hold |
14
| – | – | ﹤0.01% | 235 |
|
|
2022
Q3 | $1.13K | Buy |
+14
| New | +$1.13K | ﹤0.01% | 250 |
|